Somkuti S G, Sun J, Yowell C W, Fritz M A, Lessey B A
Department of Obstetrics and Gynecology, University of North Carolina, Chapel Hill 27599-7570, USA.
Fertil Steril. 1996 Mar;65(3):484-8.
To determine if oral contraceptive (OC) usage alters expression of integrins associated with endometrial receptivity.
Immunohistochemical staining intensity for integrins was compared in frozen sections of endometrial tissue specimens obtained from women with normal ovulatory cycles (n = 23; cycle days 20 to 24 based on LH surge) and from those taking oral contraceptives pills (n = 23; cycle days 5 to 27).
University-based outpatient infertility clinic.
Constitutive integrin expression in the endometrium (alpha 2 beta 1, alpha 3 beta 1, alpha 5 beta 1, alpha 6 beta 1, and alpha 6 beta 4) was similar in OC users and normally cycling individuals, except for an increase in epithelial alpha 3 beta 1 in OC users. Oral contraceptive use was associated with significant alterations in cycle-dependent integrin expression (alpha 1 beta 1, alpha 4 beta 1, and alpha v beta 3). Specifically, we observed increased glandular alpha 4 beta 1, and decreased alpha v beta 3 expression. The P-regulated alpha 1 subunit was present in both groups. Increased stromal alpha v and beta 3 and decreased alpha 3 beta 1 and alpha 6 beta 1 staining was observed in OC users.
Expression of those integrins most closely associated with endometrial receptivity, alpha v beta 3 and alpha 4 beta 1, is altered in the glandular epithelium of women taking OCs. Stromal integrin expression in OC users also differs from that in cycling women. These alterations in epithelial and stromal integrin expression suggest that impaired uterine receptivity is one mechanism whereby OCs exert their contraceptive actions.
确定口服避孕药(OC)的使用是否会改变与子宫内膜容受性相关的整合素的表达。
比较从有正常排卵周期的女性(n = 23;根据促黄体生成素峰确定为周期第20至24天)和服用口服避孕药的女性(n = 23;周期第5至27天)获得的子宫内膜组织标本冰冻切片中整合素的免疫组织化学染色强度。
大学附属门诊不孕症诊所。
除了服用OC的女性上皮细胞中α3β1增加外,服用OC者和正常月经周期者子宫内膜中的组成型整合素表达(α2β1、α3β1、α5β1、α6β1和α6β4)相似。口服避孕药的使用与周期依赖性整合素表达(α1β1、α4β1和αvβ3)的显著改变有关。具体而言,我们观察到腺上皮中α4β1增加,αvβ3表达减少。两组中均存在P调节的α1亚基。在服用OC的女性中观察到基质αv和β3增加,α3β1和α6β1染色减少。
服用OC的女性腺上皮中与子宫内膜容受性最密切相关的那些整合素αvβ3和α4β1的表达发生了改变。服用OC者的基质整合素表达也与月经周期正常的女性不同。上皮和基质整合素表达的这些改变表明子宫容受性受损是OC发挥避孕作用的一种机制。